Diametric Capital »

Madrigal Pharmaceuticals shares owned by Diametric Capital

Quarter-by-quarter ownership of Madrigal Pharmaceuticals (MDGL) shares owned by Diametric Capital from 13F filings

Historical chart of Diametric Capital investment in Madrigal Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Madrigal Pharmaceuticals held by Diametric Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Madrigal Pharmaceuticals by Diametric Capital

Quarter filed Position value Share count Share price at filing
2026-06-30 $515k 959 536.95

More positions owned by Diametric Capital

State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Precigen (PGEN)
Invesco Exch Traded Fd Tr Ii S&p500 Low Vol (SPLV)
Fulgent Genetics (FLGT)
Ishares Tr Msci Eafe Etf (EFA)
A2z Cust2mate Solutions Corp (AZ)
Uniqure Nv SHS (QURE)
Liquidia Corporation Com New (LQDA)
Almonty Inds Com New (ALM)
Golar Lng SHS (GLNG)
Calumet (CLMT)
Abivax Sa Sponsored Ads (ABVX)
Digital Realty Trust (DLR)
Telephone & Data Sys Com New (TDS)
MGM Resorts International. (MGM)

View all positions for Diametric Capital

Top funds holding Madrigal Pharmaceuticals

Baker Bros. Advisors
Henderson Group
Rtw Investments
Jupiter Topco
venBio Select Advisor
Paulson & Co
BlackRock
Vanguard Capital Management
Wellington Management Company
Vanguard Portfolio Management
Citadel Advisors
State Street Corporation
Susquehanna International
UBS Group
Geode Capital Management

View all funds holding Madrigal Pharmaceuticals